Subscribe to this column
Clifford A. Hudis, MD, FACP, FASCO
Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as Chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a Past President of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to the obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.
Oct 03, 2018
The chair-elect of the ASCO Health Equity Committee and I discuss concerns with proposed Medicaid work requirements and their impact on patients with cancer and their physicians.
Sep 11, 2018
We remain very concerned that the CMS proposal could harm Medicare beneficiaries who have cancer by triggering major cuts to physician reimbursement, especially for Part B drugs and for drugs that have been newly introduced to the market.
Aug 28, 2018
At the latest ASCO Board of Directors Meeting, we discussed countering biases, improving rural access to quality cancer care, and effectively adding more value to your ASCO membership.
Aug 24, 2018
ASCO's "I Live to Conquer Cancer" campaign is putting a human face on the results of cancer research and the researchers who make this progress.
Aug 07, 2018
I spoke with our current ASCO president about her theme for the year, her work with the Alliance for Clinical Trials in Oncology, and her frontier spirit.
Jul 16, 2018
Broadening eligibility critera for cancer clinical trials will give more patients the opportunity to contribute to scientific research.
Latest Blogs